Agios Pharm
AGIO · NASDAQ34.46
34.46
USD-0.89-2.52%Day Range
34.11USD
35.84USD
52 Week Range
21.18USD
62.58USD
Market Cap
2.02BUSD
Get Full Access with Profit PRO
See which Billionaires own this investment
About
General Information
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00847X1046
CUSIP
00847X104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
Highlights
PE Ratio
2.96
PEG Ratio
-
Book Value
28.53
Dividend Share
-
Dividend Yield
-
Earnings Share
11.66
Wall Street Target Price
57
EPS Estimate Current Year
11.21
EPS Estimate Next Year
-5.796
EPS Estimate Current Quarter
1.11
EPS Estimate Next Quarter
-1.73
Most Recent Quarter
-
Profitability
Revenue TTM
32,871,000
Gross Profit TTM
-266,584,992
EBITDA
-401,288,000
Profit Margin
2051.38%
Return On Assets TTM
-18.18%
Return On Equity TTM
53.66%
Revenue Per Share TTM
0.582
Qtly Revenue Growth YOY
21.20%
Diluted Eps TTM
11.66
Qtly Earnings Growth YOY
0.00%
Valuation
Trailing PE
2.96
Forward PE
2
Price Sales TTM
59.7871
Price Book MRQ
1.2404
Enterprise Value Revenue
32
Enterprise Value EBITDA
-2
Peers analysis
- UCBJYUCB SA ADR
99.44
3.39% - ALNYAlnylam Pharmaceuticals Inc
279.00
1.22% - CSLLYCSL Ltd
85.68
0.87% - ARGNFargenx SE
625.30
0.00% - UCBJFUCB SA
190.00
0.00%
- BNTXBioNTech SE
118.14
-3.35% - REGNRegeneron Pharmaceuticals Inc
675.00
-2.82% - CMXHFCSL Limited
164.85
-1.47% - ARGXargenx NV ADR
648.94
-0.54% - VRTXVertex Pharmaceuticals Inc
439.62
-0.08%
What are you waiting for?Start making profit today
©
2025
All rights reserved